Advertisement

Differentiation between Pathogenic and Non-Pathogenic Entamoeba Histolytica

  • D. Mirelman
Part of the Federation of European Microbiological Societies Symposium Series book series (FEMS, volume 51)

Abstract

The spectrum of disease in amebiasis is remarkable. It is estimated that there are approximately 500 million infections/year, but most of them are asymptomatic and only about 10% of the cases develop into disease (1, 2). The prevailing hypothesis was that there are two distinct, albeit morphologically identical, species of E. histolytica, a pathogenic one which can cause disease and the second, a non pathogenic variety which is a commensal and will never cause disease (3). Numerous investigators are searching for biochemical and molecular differences between these two types of amoebae which may support this theory. Martinez-Palomo showed differences in agglutinability by the lectin Concanavalin A in E. histolytica isolates obtained from patients with invasive amebiasis and from symptomless cyst passers (4). Sargeaunt and his colleagues (5, 6) have found that the two classes of amoebae can be differentiated by the electrophoretic migration of two isoenzymes, hexokinase and phospho glucomutase. The main questions that were raised, however, were (I) could persons infected with amoebae that have the non pathogenic isoenzyme patterns ever develop disease, (II) could asymptomatic carriers serve as the source of infection that would have clinical manifestations in other subjects, and (III) should asymptomatic carriers infected with amoebae that possess non pathogenic isoenzymes be subjected to drug therapy. Classification of E. histolytica into pathogenic or non pathogenic species by their isoenzyme electrophoretic patterns appears to be of no significant value because, as previously reported for other protozoa, notably Tetrahymena (7) and Paramecium (8), isoenzyme migration is not always a stable marker.

Keywords

Asymptomatic Carrier Entamoeba Histolytica Phospho Glucomutase Isoenzyme Pattern Stable Marker 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Martinez-Palomo, A. 1986. In Martinez-Palomo A. ed: “Amebiasis: Human Parasitic Diseases”, Elsevier Biomed. Div. Amsterdam.Google Scholar
  2. 2.
    Walsh, J.A. 1988. In Ravdin J.I. ed: “Amebiasis: Human Infection by Entamoeba histolytica”, John Wiley & Sons, New York, p. 93.Google Scholar
  3. 3.
    Brumpt, E. 1925. Bull de I’Acad Med. Paris 94:942.Google Scholar
  4. 4.
    Martinez-Poloma, A., Gonzales-Robles, A., de la Torre, M. 1973. Nature 245:186.CrossRefGoogle Scholar
  5. 5.
    Sargeaunt, P.G., Williams, J.E. 1978. Trans R Soc Trop Med Hyg 72:164.PubMedCrossRefGoogle Scholar
  6. 6.
    Sargeaunt, P.G. 1987. Parasitol Today 3:40.PubMedCrossRefGoogle Scholar
  7. 7.
    Allen, S.L. 1968. Ann NY Acad Sci 151:190.PubMedCrossRefGoogle Scholar
  8. 8.
    Rowe, E., Gibson, I., Cavill, A. 1970. Biochem Genetics 5:151.CrossRefGoogle Scholar
  9. 9.
    Mirelman, D. et al. 1986. Exp Parasitol 62:142.PubMedCrossRefGoogle Scholar
  10. 10.
    Mirelman, D. et al. 1986. Infect Immun 54:827.PubMedGoogle Scholar
  11. 11.
    Strachan W.D. et al. 1988. Lancet 12:561.CrossRefGoogle Scholar
  12. 12.
    Mirelman, D., Ravdin, J.I. 1986. In: Microbial Lectins and Agglutinins: Properties and Biological Activity. D. Mirelman, ed. pp.319–334, John Wiley & Sons, N.Y.Google Scholar
  13. 13.
    Petri, W.A. et al. 1987. J. Clin. Invest. 80:123.CrossRefGoogle Scholar
  14. 14.
    Petri, W.A. et al. 1989. J. Biol. Chem. 264:3007.PubMedGoogle Scholar
  15. 15.
    Huber, M. et al. 1989. Mol. Biochem. Parasitol. 32:285.PubMedCrossRefGoogle Scholar
  16. 16.
    Garfinkel et al. 1989. Infect. Immun. 57:926.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • D. Mirelman
    • 1
  1. 1.Macarthur Center for Molecular Biology of Tropical Diseases and Department of BiophysicsWeizmann Institute of ScienceRehovotIsrael

Personalised recommendations